OMCL
Omnicell, Inc. · Healthcare · Medical - Healthcare Information Services
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +2 | 36.92M | $1.52B | +8 | −7 |
| Q1 2026 | 100 | +1 | 36.98M | $1.23B | +6 | −5 |
| Q4 2025 | 99 | +2 | 40.13M | $1.82B | +2 | n/a |
| Q3 2025 | 18 | 0 | 22.98M | $699.67M | +1 | −1 |
| Q2 2025 | 15 | -1 | 21.34M | $627.32M | +1 | −2 |
| Q1 2025 | 13 | -1 | 6.74M | $235.79M | n/a | −1 |
| Q4 2024 | 14 | +1 | 6.20M | $275.97M | +1 | n/a |
| Q3 2024 | 12 | -1 | 3.89M | $169.70M | n/a | −1 |
| Q2 2024 | 13 | n/a | 3.69M | $99.83M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.10M | n/a | $29.83M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | D. E. Shaw & Co. ✦ | 1.09M | n/a | $29.45M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 3 | Wellington Management ✦ | 418.39K | n/a | $11.33M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 4 | Citadel Advisors ✦ | 389.64K | n/a | $10.55M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 131.30K | n/a | $3.55M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 123.89K | n/a | $3.35M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 110.77K | n/a | $3.00M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Millennium Management ✦ | 97.00K | n/a | $2.63M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 59.97K | n/a | $1.62M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 49.07K | n/a | $1.33M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | T. Rowe Price ✦ | 40.45K | n/a | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 39.31K | n/a | $1.06M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 38.29K | n/a | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 5.77M shares, $5.60M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.